Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy
Clinical trial NCT05136456 · UNKNOWN
Trial details
- NCT number
- NCT05136456
- Sponsor
- Reistone Biopharma Company Limited
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2023-08-28
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.